Gyermekkori daganatok: vizsgálatok itt: Németország
144 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePeptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA
- Where
- Tübingen
- Életkor
- 12 év and over
- People
- 20
- Run by
- University Hospital Tuebingen
See details and how to joinNCT06789198 · EU 2024-519387-41-00 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Erlangen, Essen, Munich
- Életkor
- 12 év to 100 év
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - No phaseTaking peopleEvaluation of an Exercise Intervention During Intensive Medical Treatment in Pediatric Oncology.
- Where
- Berlin, Bonn, Cologne, Essen, Frankfurt, Hamburg, Jena, Mainz, München, Nuremberg, Stuttgart, Ulm
- Életkor
- 3 év to 18 év
- People
- 346
- Run by
- Universität Duisburg-Essen
See details and how to joinNCT07647471 - No phaseNot yet taking people in NémetországTargeted Pediatric High-Grade Glioma Therapy
- Where
- Heidelberg
- Életkor
- 12 hónap to 39 év
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - 3. fázisTaking peopleSIOP RANDOMET 2017
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Göttingen, Greifswald, Halle Saale, Hamburg, Hannover, Heidelberg, Heilbronn, Homburg, Jena, Karlsruhe, Kassel, Kiel, Köln, Leipzig, Lübeck, Mainz, Mannheim, München, Münster, Nürnberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Stuttgart, Tübingen, Ulm, Würzburg
- Életkor
- Up to 17 év
- People
- 409 worldwide
- Run by
- GPOH gGmbH
See details and how to join2023-508926-91-00 - 1/2. fázisTaking peoplePhase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE)
- Where
- Augsburg, Berlin, Essen, Hamburg, Heidelberg
- Életkor
- Up to 64 év
- People
- 34 worldwide
- Run by
- Universitaetsklinikum Heidelberg AöR
See details and how to join2024-516896-34-00 - 3. fázisTaking peopleSIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
- Where
- Aachen, Augsburg, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Cologne, Cottbus, Dortmund, Dresden, Duisburg, Düsseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Greifswald, Halle (Saale), Hamburg, Hanover, Heidelberg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Luebeck, Magdeburg, Mainz, Mannheim, Minden, Muenster, München, Munich, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 64 év
- People
- 311 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-510578-25-00 - 2/3. fázisFut, nem toborozAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Aachen, Berlin, Bonn, Duesseldorf, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Greifswald, Halle (Saale), Hamburg, Hanover, Heidelberg, Jena, Kiel, Leipzig, Muenster, Munich, Regensburg, Tuebingen, Ulm, Wuerzburg
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - 2. fázisTaking peopleNivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
- Where
- Aachen, Berlin, Bielefeld, Bonn, Cologne, Cottbus, Dortmund, Dresden, Duesseldorf, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Goettingen, Göttingen, Greifswald, Halle (saale), Hamburg, Jena, Kassel, Kiel, Magdeburg, Mainz, Mannheim, Muenster, Munich, Ratisbon, Tuebingen, Wuerzburg
- Életkor
- Up to 64 év
- People
- 57
- Run by
- GPOH gGmbH
See details and how to join2022-500676-59-00 - 2. fázisNot yet taking people in NémetországStudy of Olutasidenib and Temozolomide in HGG
- Where
- Heidelberg
- Életkor
- 12 év to 39 év
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - 2. fázisNot yet taking people in NémetországStudy to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
- Where
- Dresden, Erlangen, Essen, Frankfurt Am Main, Hamburg
- Életkor
- Up to 17 év
- People
- 16 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522138-29-00 - No phaseTaking peopleIntraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma
- Where
- Munich
- People
- 1000
- Run by
- LMU Klinikum
See details and how to joinNCT06600165 - No phaseTaking peopleGerman Adrenocortical Carcinoma Registry
- Where
- Würzburg
- People
- 1000
- Run by
- University of Wuerzburg
See details and how to joinNCT00453674 - No phaseCsak meghívásosADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
- Where
- Munich
- Életkor
- 4 év to 18 év
- People
- 20
- Run by
- Technical University of Munich
See details and how to joinNCT05235633 - No phaseTaking peopleCerebellar Mutism Syndrome Study
- Where
- Leipzig, Tübingen
- Életkor
- Up to 18 év
- People
- 2000 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766 - 3. fázisTaking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Bielefeld, Bonn, Bremen, Hamburg, Krefeld, Mainz
- Életkor
- 0 év to 45 év
- People
- 6430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - 1. fázisCsak meghívásosAdoptive Cell Therapy Long-term Follow-up (LTFU) Study
- Where
- Cologne, Munich
- People
- 250 worldwide
- Run by
- USWM CT, LLC
See details and how to joinNCT03391778 - 2. fázisTaking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- Essen, Freiburg im Breisgau, Hamburg
- Életkor
- 1 év to 39 év
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - No phaseTaking peopleFit to Fight Childhood Cancer
- Where
- Mainz
- Életkor
- 3 év to 21 év
- People
- 100
- Run by
- Johannes Gutenberg University Mainz
See details and how to joinNCT05867186 - 2. fázisNot yet taking people in NémetországRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
- Where
- Augsburg, Erlangen, Freiburg im Breisgau, Hamburg, Jena, Mainz, Muenster
- Életkor
- Up to 64 év
- People
- 31 worldwide
- Run by
- Pediatric Research International GmbH
See details and how to join2025-521390-14-00 - No phaseTaking peopleHealth Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
- Where
- Essen
- Életkor
- Up to 22 év
- People
- 2670 worldwide
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04746729 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Berlin, Frankfurt am Main, Heidelberg
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 3. fázisTaking peopleVO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
- Where
- Berlin, Dresden, Erfurt, Essen, Frankfurt Am Main, Hamburg, Heidelberg, Kiel, Mainz, Munich, Tuebingen
- Életkor
- 12 év and over
- People
- 400 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00 - 1/2. fázisFut, nem toborozStudy of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Where
- Essen, Hamburg, Immenhausen, Minden
- Életkor
- 12 év and over
- People
- 361 worldwide
- Run by
- ModernaTX, Inc.
See details and how to joinNCT05533697 · EU 2023-504506-11-00 - 1. fázisTaking peopleInternational open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
- Where
- Berlin, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Greifswald, Hamburg, Heidelberg, Leipzig, Mainz
- People
- 18 worldwide
- Run by
- GPOH gGmbH
See details and how to join2024-515245-42-00